Skip to main content
Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.182
+0.062 (1.99%)
At close: Apr 28, 2026, 4:00 PM EDT
3.200
+0.018 (0.57%)
After-hours: Apr 28, 2026, 4:00 PM EDT

Lisata Therapeutics Revenue

In the year 2025, Lisata Therapeutics had annual revenue of $170.00K, down -83.00%. Lisata Therapeutics had revenue of $100.00K in the quarter ending December 31, 2025, a decrease of -90.00%.

Revenue (ttm)
$170.00K
Revenue Growth
-83.00%
P/S Ratio
170.02
Revenue / Employee
$8,095
Employees
21
Market Cap
28.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025170.00K-830.00K-83.00%
Dec 31, 20241.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
Neuphoria Therapeutics 14.99M
Apollomics 8.99M
Kyntra Bio 6.44M
Dyadic International 3.09M
Outlook Therapeutics 205.70K
Senti Biosciences Holdings 22.00K
Revenue Rankings

LSTA News

More News